Results 81 to 90 of about 14,771 (224)

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Medication-overuse headache: a review

Journal of Pain Research, 2014
Espen Saxhaug Kristoffersen,1–3 Christofer Lundqvist1,2,41Research Centre, Akershus University Hospital, Lørenskog, 2Department of Neurology, Akershus University Hospital, Nordbyhagen, 3Department of General Practice, Institute of Health and
Kristoffersen ES, Lundqvist C
doaj  

Chronic daily headaches

Annals of Indian Academy of Neurology, 2012
Chronic Daily Headache is a descriptive term that includes disorders with headaches on more days than not and affects 4% of the general population. The condition has a debilitating effect on individuals and society through direct cost to healthcare and ...
Fayyaz Ahmed, Rajsrinivas Parthasarathy, Modar Khalil   +2 more
doaj   +1 more source

Memantine for prevention of migraine: a retrospective study of 60 cases. [PDF]

, 2007
The objective was to retrospectively characterise the efficacy of memantine as preventive therapy in a series of patients with frequent migraine. Patients in a university headache clinic completed a survey regarding their experience with memantine, and ...
Brennan, Kevin C, Charles, Andrew, Flippen, Charles, Romero Reyes, Marcela   +3 more
core   +1 more source

Regulatory compliance and support for altered management of the exotic pet trade

Conservation Biology, EarlyView.
Abstract Globally, the exotic pet trade has contributed to species invasion, disease, and animal welfare risks. Although scientists have advocated for increased trade regulation, the success of management and regulatory efforts depends on compliance by participants in the exotic pet trade. We used a regulatory compliance framework to investigate exotic
Elizabeth N. Pratt, Julie L. Lockwood, Elizabeth G. King, Elizabeth F. Pienaar   +3 more
wiley   +1 more source

Medication Overuse Headache

Physical Medicine and Rehabilitation Clinics of North America
Abstract Affecting 2–3% of the population, medication-overuse headache is headache that occurs on ≥15 days a month associated with frequent use of acute-relief medication in susceptible patients. Patients with a predisposition to migraine or tension-type headache seem prone to medication-overuse headache.
Aleksenko D, Lui F, Sánchez-Manso JC.
europepmc   +7 more sources

Medication overuse headache, addiction and personality pathology: a controlled study by SWAP-200 [PDF]

, 2019
Background: Medication Overuse Headache (MOH) is a type of chronic headache, whose mechanisms are still unknown. Some empirical investigations examining the addiction-like behaviors and processes, as well as personality characteristics underlying MOH ...
Cristofalo, Patrizia, Galli, Federica, Gualco, Ivan, Lingiardi, Vittorio, Parolin, Micol, Sances, Grazia, Simonelli, Alessandra, Tanzilli, Annalisa, Tassorelli, Cristina   +8 more
core   +1 more source

Effectiveness and acceptability of oral migraine preventives: A prospective, observational study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To explore the adherence, effectiveness, safety, tolerability, and acceptability of frequently used oral migraine preventive drugs in a real‐world setting. Background Oral migraine preventives are previously mainly explored in randomized controlled trials, whereas real‐world data on treatment outcomes remain limited. Methods MigriNor
Hedda S. Riise, Melanie R. Simpson, Ketil A. Espnes, Erling A. Tronvik, Andreas K. Husøy, Lise R. Øie, Anker Stubberud, Emil Kofoed, Aurora H. Alstad, Hedda H. Hagen, Maren G. Lien, Marie L. Stavseng, Ella R. Sæther, Tore Wergeland   +13 more
wiley   +1 more source

Study protocol: Brief intervention for medication overuse headache - A double-blinded cluster randomised parallel controlled trial in primary care

BMC Neurology, 2012
Background Chronic headache (headache ≥ 15 days/month for at least 3 months) affects 2–5% of the general population. Medication overuse contributes to the problem.
Kristoffersen Espen, Straand Jørund, Benth Jūratė, Russell Michael, Lundqvist Christofer   +4 more
doaj   +1 more source

A 2 years prospective evaluation study on onabotulinumtoxinA 195 U in chronic migraine [PDF]

, 2015
Background: OnabotulinumtoxinA (Botox®) is the first and so far the only treatment to receive a specific license for prevention of chronic migraine (CM). In our Headache Clinic the therapy with onabotulinumtoxinA is routinely administered to CM patients
D'Alonzo, Lidia, LALA, NOEMI, MARTELLETTI, Paolo, NEGRO, ANDREA   +3 more
core   +2 more sources